Showing 37 to 48 of 93 results
Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump signed an executive order to lower prescription drug prices by modifying the Medicare drug price negotiation program, expediting generic approvals, increasing low-cost imports, and potentially reclassifying some drugs for over-the-counter sales, specifically mentioning insulin and ep...
Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump signed an executive order to lower prescription drug prices by modifying the Medicare drug price negotiation program, expediting generic approvals, increasing low-cost imports, and potentially reclassifying some drugs for over-the-counter sales, specifically mentioning insulin and ep...
Progress
40% Bias Score
Blackburn Rebuts Claims of Republican Social Security Cuts
Senator Marsha Blackburn denies Republican plans to cut Social Security and Medicare, highlighting the RETIREES FIRST Act to raise the income threshold for Social Security taxes and plans to remove federal income tax from Social Security benefits; she criticizes California's Medi-Cal expansion for i...
Blackburn Rebuts Claims of Republican Social Security Cuts
Senator Marsha Blackburn denies Republican plans to cut Social Security and Medicare, highlighting the RETIREES FIRST Act to raise the income threshold for Social Security taxes and plans to remove federal income tax from Social Security benefits; she criticizes California's Medi-Cal expansion for i...
Progress
52% Bias Score
Senate Confirms Mehmet Oz to Lead CMS
The U.S. Senate confirmed Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS), overseeing healthcare for nearly half of Americans, following a 53-45 partisan vote; his past promotion of unproven treatments and controversial stances have raised concerns.
Senate Confirms Mehmet Oz to Lead CMS
The U.S. Senate confirmed Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS), overseeing healthcare for nearly half of Americans, following a 53-45 partisan vote; his past promotion of unproven treatments and controversial stances have raised concerns.
Progress
48% Bias Score
Trump Administration Rejects Medicare Coverage for Obesity Medications
The Trump administration decided against covering costly obesity medications under Medicare Part D, rejecting a Biden-era proposal that would have cost taxpayers up to $35 billion over 10 years, despite polls showing public support and evidence suggesting that treating obesity can reduce long-term h...
Trump Administration Rejects Medicare Coverage for Obesity Medications
The Trump administration decided against covering costly obesity medications under Medicare Part D, rejecting a Biden-era proposal that would have cost taxpayers up to $35 billion over 10 years, despite polls showing public support and evidence suggesting that treating obesity can reduce long-term h...
Progress
48% Bias Score
Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand coverage of costly anti-obesity drugs to over 7 million Medicare and Medicaid beneficiaries, citing cost concerns and the need for further review, despite potential benefits and growing adoption by some states.
Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand coverage of costly anti-obesity drugs to over 7 million Medicare and Medicaid beneficiaries, citing cost concerns and the need for further review, despite potential benefits and growing adoption by some states.
Progress
48% Bias Score
Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand coverage of expensive anti-obesity drugs to over 7 million Americans on Medicare and Medicaid, citing potential fiscal impacts and the need for further review, leaving millions without access to these medications.
Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand coverage of expensive anti-obesity drugs to over 7 million Americans on Medicare and Medicaid, citing potential fiscal impacts and the need for further review, leaving millions without access to these medications.
Progress
44% Bias Score
Australia's Healthcare System Needs Urgent Reform
Australia's healthcare system, while strong, needs reform in five key areas: financial barriers, chronic disease management, mental and dental health, public hospital funding, and workforce shortages; the upcoming election will decide the next steps.
Australia's Healthcare System Needs Urgent Reform
Australia's healthcare system, while strong, needs reform in five key areas: financial barriers, chronic disease management, mental and dental health, public hospital funding, and workforce shortages; the upcoming election will decide the next steps.
Progress
52% Bias Score
CMMI's Failure: \$5 Billion Overspend, Unchecked Power
The Center for Medicare and Medicaid Innovation (CMMI) has increased net federal spending by over \$5 billion in its first decade, failing to meet its goals and overstepping its authority; its projected \$1.3 billion spending increase over 2021-2030 makes its elimination a fiscally responsible and n...
CMMI's Failure: \$5 Billion Overspend, Unchecked Power
The Center for Medicare and Medicaid Innovation (CMMI) has increased net federal spending by over \$5 billion in its first decade, failing to meet its goals and overstepping its authority; its projected \$1.3 billion spending increase over 2021-2030 makes its elimination a fiscally responsible and n...
Progress
60% Bias Score
Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand Medicare and Medicaid coverage of expensive anti-obesity drugs, citing fiscal concerns and the need for further review, impacting millions of Americans and leaving access to these medications limited.
Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand Medicare and Medicaid coverage of expensive anti-obesity drugs, citing fiscal concerns and the need for further review, impacting millions of Americans and leaving access to these medications limited.
Progress
52% Bias Score
Controversial TV Doctor Confirmed to Lead US Healthcare Agency
The US Senate confirmed Dr. Mehmet Oz, a controversial TV personality and former heart surgeon, to lead the Centers for Medicare & Medicaid Services (CMS), despite criticism over his past promotion of unproven medical treatments and politically charged statements; the Senate's 53-45 party-line vote ...
Controversial TV Doctor Confirmed to Lead US Healthcare Agency
The US Senate confirmed Dr. Mehmet Oz, a controversial TV personality and former heart surgeon, to lead the Centers for Medicare & Medicaid Services (CMS), despite criticism over his past promotion of unproven medical treatments and politically charged statements; the Senate's 53-45 party-line vote ...
Progress
48% Bias Score
Trump Administration Rejects Medicare Coverage for Weight-Loss Drugs
The Trump administration blocked a Biden-era proposal to cover weight-loss drugs under Medicare and Medicaid, citing concerns over the potential $35 billion cost over a decade and the need for further review. This decision reverses a plan to interpret existing statutes to allow such coverage, based ...
Trump Administration Rejects Medicare Coverage for Weight-Loss Drugs
The Trump administration blocked a Biden-era proposal to cover weight-loss drugs under Medicare and Medicaid, citing concerns over the potential $35 billion cost over a decade and the need for further review. This decision reverses a plan to interpret existing statutes to allow such coverage, based ...
Progress
48% Bias Score
2025 Australian Federal Election: Albanese vs. Dutton
The 2025 Australian federal election pits incumbent Prime Minister Anthony Albanese against Opposition Leader Peter Dutton, with key policy debates centering on healthcare spending, public service cuts, and the impact of the Voice referendum on national unity. Albanese champions Medicare and social ...
2025 Australian Federal Election: Albanese vs. Dutton
The 2025 Australian federal election pits incumbent Prime Minister Anthony Albanese against Opposition Leader Peter Dutton, with key policy debates centering on healthcare spending, public service cuts, and the impact of the Voice referendum on national unity. Albanese champions Medicare and social ...
Progress
44% Bias Score
Showing 37 to 48 of 93 results